Cystic Fibrosis Foundation is located in Bethesda, MD. The organization was established in 1957. According to its NTEE Classification (G20) the organization is classified as: Birth Defects & Genetic Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2019, Cystic Fibrosis Foundation employed 888 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations.
For the year ending 12/2019, Cystic Fibrosis Foundation generated $605.8m in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 32.5% each year . All expenses for the organization totaled $348.7m during the year ending 12/2019. While expenses have increased by 12.6% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Cystic Fibrosis Foundation has awarded 2,246 individual grants totaling $783,053,974. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2019
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF THE CYSTIC FIBROSIS FOUNDATION IS TO CURE CYSTIC FIBROSIS AND TO PROVIDE ALL PEOPLE WITH CF THE OPPORTUNITY TO LEAD LONG, FULFILLING LIVES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
MEDICAL PROGRAMS - SINCE 1955, THE CYSTIC FIBROSIS FOUNDATION HAS BEEN DEDICATED TO CURING AND CONTROLLING CYSTIC FIBROSIS (CF). THE CYSTIC FIBROSIS FOUNDATION IS THE WORLD'S LEADER IN THE SEARCH FOR A CURE FOR CYSTIC FIBROSIS, A LIFE-THREATENING GENETIC DISEASE THAT AFFECTS MORE THAN 30,000 PEOPLE IN THE UNITED STATES, AND 70,000 WORLDWIDE. THE FOUNDATION ACCOMPLISHES ITS MISSION BY FUNDING LIFE-SAVING RESEARCH TO DISCOVER AND DEVELOP EFFECTIVE THERAPIES FOR PEOPLE WITH CF. THE CF FOUNDATION HAS FUNDED HUNDREDS OF MILLIONS OF DOLLARS OF RESEARCH COSTS TO HELP DISCOVER/DEVELOP CF DRUGS AND THERAPIES. THROUGH THE FOUNDATION'S EFFORTS, THE LIFE EXPECTANCY OF PEOPLE WITH CF HAS MORE THAN DOUBLED IN THE LAST 30 YEARS, AND RESEARCH TO FIND A CURE IS MORE PROMISING THAN EVER BEFORE. IN 2019, THE CF FOUNDATION INVESTED $201 MILLION INTO RESEARCH AND CARE. THE CF FOUNDATION HAS ATTRACTED SIGNIFICANT INDUSTRY INVOLVEMENT IN THE FIGHT AGAINST CF BY FUNDING CONTRACTED DRUG DISCOVERY AND DEVELOPMENT RESEARCH CONDUCTED BY BIOTECHNOLOGY COMPANIES. IT ALSO PROVIDES MATCHING AWARDS TO CF DRUG DEVELOPERS FOR CF RESEARCH AND FUNDS A SPECIALIZED CF CLINICAL TRIALS NETWORK OF NEARLY 90 FOUNDATION-ACCREDITED CARE CENTERS. AS A RESULT OF THIS FUNDING, IN 2019 THE CF DRUG DEVELOPMENT PIPELINE HAD 29 THERAPIES IN DEVELOPMENT IN ADDITION TO 15 FDA APPROVED TREATMENTS THAT ADDRESS COMPLICATIONS LIKE INFECTIONS AND A POTENTIAL CURE. THE TREATMENT AND CARE PROTOCOLS DEVELOPED BY THE CF FOUNDATION ARE HELPING TENS OF THOUSANDS OF PEOPLE WITH THE DISEASE LIVE LONGER, HEALTHIER LIVES. TO SUPPORT ITS MISSION, THE FOUNDATION FUNDS AND ACCREDITS A NATIONWIDE NETWORK OF MORE THAN 130 CARE CENTERS. THE CARE CENTER NETWORK PROVIDES THE BEST CARE FOR PEOPLE WITH CF AND HAS BEEN RECOGNIZED BY THE NATIONAL INSTITUTES OF HEALTH AS A MODEL OF CARE FOR A CHRONIC DISEASE. IN 2019, THE FOUNDATION PROVIDED MORE THAN $41 MILLION OF SUPPORT FOR CARE CENTERS AND CLINICIANS. THE FOUNDATION'S PATIENT REGISTRY COLLECTS INFORMATION ON THE HEALTH STATUS OF MORE THAN 31,199 PEOPLE WITH CF, PROVIDING CAREGIVERS AND RESEARCHERS CRITICAL INFORMATION TO HELP IDENTIFY NEW HEALTH TRENDS AND EFFECTIVE TREATMENTS AND IMPROVE THE QUALITY OF CF CARE. THE PATIENT REGISTRY IS AN INTERNATIONALLY RECOGNIZED MODEL FOR OTHER NONPROFIT HEALTH ORGANIZATIONS, INCLUDING CF ADVOCACY GROUPS.
COMMUNITY SERVICES - THE FOUNDATION PROVIDES MUCH-NEEDED SUPPORT FOR PATIENTS AND THEIR FAMILIES AS THEY MANAGE THE PHYSICAL, EMOTIONAL, AND FINANCIAL CHALLENGES OF LIVING WITH CF - FROM SUPPORTING SPECIALIZED QUALITY CF CARE, TO PROVIDING INFORMATION AND RESOURCES TO HELP PEOPLE WITH CF BECOME EFFECTIVE PARTNERS IN THEIR CARE TO PROGRAMS TO HELP AFFECT THE ISOLATION OF LIVING WITH THIS DISEASE. APPROXIMATELY 31,199 PEOPLE WITH CF WERE SERVED IN 2019, INCLUDING APPROXIMATELY 766 INDIVIDUALS WHO WERE NEWLY DIAGNOSED. LACK OF ADEQUATE INSURANCE COVERAGE FOR CF MEDICATIONS HAS BEEN A CONSISTENT CONCERN FOR THOSE LIVING WITH THE DISEASE AND THEIR FAMILIES. COMPASS IS A HIGHLY PERSONALIZED SERVICE TAILORED TO AN INDIVIDUAL'S CIRCUMSTANCES RELATED TO COMPLEX INSURANCE, FINANCIAL, LEGAL, AND OTHER ISSUES THAT CAN PREVENT ACCESS TO MUCH-NEEDED CF THERAPIES AND CARE. IN 2019, SKILLED CASE MANAGERS ADDRESSED MORE THAN 6,000 CASES FOR PEOPLE WITH CF, THEIR FAMILIES, AND THEIR PROVIDER NETWORK, INCLUDING UNDERSTANDING AND MAXIMIZING THEIR INSURANCE COVERAGE AND BENEFITS, AS WELL AS GETTING HELP WITH OTHER NEEDS RELATED TO DAILY LIFE WITH CF. CASE MANAGERS ALSO ASSISTED WITH FINDING RESOURCES FOR ISSUES RELATED TO LIFE WITH CF THAT CAN AFFECT ACCESS, INCLUDING BASIC LIVING AND FOOD EXPENSES. TODAY, MORE THAN HALF OF ALL PEOPLE WITH CF ARE AGE 18 OR OLDER. IN 2019, APPROXIMATELY 1,500 PEOPLE WITH CF AND THEIR FAMILY MEMBERS JOINED VIRTUAL EVENTS DESIGNED BY AND FOR ADULTS WITH CF, FAMILY, CLINICIANS AND RESEARCHERS INCLUDING BREATHECON, FAMILYCON AND RESEARCHCON, THAT PROVIDE AN OPPORTUNITY FOR THE CF COMMUNITY TO CONNECT, SHARE, AND LEARN FROM PEERS THROUGH OPEN AND HONEST DIALOGUE.
PUBLIC AND PROFESSIONAL INFORMATION AND EDUCATION - TO BROADEN ITS REACH AND TO SUPPORT ITS MISSION, THE CF FOUNDATION HAS PROGRAMS DESIGNED TO IMPROVE THE KNOWLEDGE OF PEOPLE WITH CF AND THEIR FAMILIES, MEDICAL PROFESSIONALS AND THE GENERAL PUBLIC REGARDING THE DISEASE. IN 2019, THERE WERE 27 PUBLICATIONS AND 39 VIDEOS PRODUCED AND MADE AVAILABLE TO SUPPORT EDUCATION AND AWARENESS. YEAR-ROUND, MEETINGS AND CONFERENCES PROVIDE UPDATES FOR CF RESEARCHERS, PHYSICIANS AND ALLIED HEALTH PROFESSIONALS AND OPPORTUNITIES FOR COLLABORATION ON FUTURE CF RESEARCH PROJECTS AND TREATMENT/CARE EFFORTS. IN 2019, OVER 3,063,346 UNIQUE VISITORS CAME TO THE CF FOUNDATION'S WEBSITE. NEW CONTENT ON CFF.ORG IN 2019 INCLUDED THE LAUNCH OF 11 NEW SECTIONS AND 90 BLOG POSTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Preston Campbell MD President & CEO | OfficerTrustee | 40 | $1,296,038 |
Jack Mahler MD Chief Investment Officer | Officer | 40 | $1,129,788 |
Marc S Ginsky Executive Vp, COO & Secretary | Officer | 40 | $798,697 |
Earl Lee Managing Director, Investments | 40 | $795,644 | |
Eric Koehrsen Managing Director, Investments | 40 | $724,272 | |
Vera H Twigg Executive VP & CFO | Officer | 40 | $616,492 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Vertex Pharmaceuticals Inc Contracted Research | 12/30/19 | $12,500,000 |
Clinical Research Sequencing Platfo Contracted Research | 12/30/19 | $6,441,110 |
Corbus Pharmaceuticals Inc Contracted Research | 12/30/19 | $5,000,000 |
Laurent Pharmaceuticals Inc Contracted Research | 12/30/19 | $3,600,000 |
Arcturus Therapeutics Inc Contracted Research | 12/30/19 | $4,100,901 |
Statement of Revenue | |
---|---|
Federated campaigns | $508,229 |
Membership dues | $0 |
Fundraising events | $80,308,624 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $28,078,037 |
Noncash contributions included in lines 1a–1f | $10,918,240 |
Total Revenue from Contributions, Gifts, Grants & Similar | $108,894,890 |
Total Program Service Revenue | $4,147,243 |
Investment income | $73,149,393 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $44,535,937 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $368,640,932 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $126,193 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $605,778,425 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $143,401,389 |
Grants and other assistance to domestic individuals. | $204,262 |
Grants and other assistance to Foreign Orgs/Individuals | $11,642,991 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $6,729,509 |
Compensation of current officers, directors, key employees. | $1,613,438 |
Compensation to disqualified persons | $171,700 |
Other salaries and wages | $71,752,291 |
Pension plan accruals and contributions | $5,202,675 |
Other employee benefits | $10,575,751 |
Payroll taxes | $5,037,240 |
Fees for services: Management | $0 |
Fees for services: Legal | $1,127,995 |
Fees for services: Accounting | $309,350 |
Fees for services: Lobbying | $720,241 |
Fees for services: Fundraising | $323,686 |
Fees for services: Investment Management | $3,272,948 |
Fees for services: Other | $6,340,491 |
Advertising and promotion | $12,625 |
Office expenses | $6,140,270 |
Information technology | $11,371,753 |
Royalties | $0 |
Occupancy | $6,738,238 |
Travel | $2,798,639 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $7,123,256 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $4,034,528 |
Insurance | $901,415 |
All other expenses | $0 |
Total functional expenses | $348,650,099 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $81,770 |
Savings and temporary cash investments | $69,282,429 |
Pledges and grants receivable | $5,560,596 |
Accounts receivable, net | $23,594,344 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $344,669 |
Prepaid expenses and deferred charges | $5,846,146 |
Net Land, buildings, and equipment | $11,114,652 |
Investments—publicly traded securities | $3,325,008,913 |
Investments—other securities | $1,005,305,643 |
Investments—program-related | $1,000,000 |
Intangible assets | $0 |
Other assets | $29,371,920 |
Total assets | $4,476,511,082 |
Accounts payable and accrued expenses | $38,067,909 |
Grants payable | $196,869,140 |
Deferred revenue | $4,865,201 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $239,802,250 |
Net assets without donor restrictions | $4,226,469,269 |
Net assets with donor restrictions | $10,239,563 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $4,476,511,082 |
Over the last fiscal year, Cystic Fibrosis Foundation has awarded $143,388,595 in support to 606 organizations.
Grant Recipient | Amount |
---|---|
Seattle, WA PURPOSE: CLINICAL RESEARCH | $9,086,103 |
Seattle, WA PURPOSE: CLINICAL RESEARCH CENTER | $8,852,451 |
Hanover, NH PURPOSE: QUALITY IMPROVEMENT | $4,317,660 |
Germantown, MD PURPOSE: PATIENT ASSISTANCE | $3,400,000 |
Cincinnati, OH PURPOSE: CLINICAL CARE RESEARCH | $2,927,422 |
Chapel Hill, NC PURPOSE: THERAPEUTICS DISCOVERY RESEARCH | $2,856,504 |
Over the last fiscal year, we have identified 118 grants that Cystic Fibrosis Foundation has recieved totaling $1,354,854.
Awarding Organization | Amount |
---|---|
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $805,390 |
Cure Cf Louisville, KY PURPOSE: CURE CYSTIC FIBROSIS | $50,000 |
Petoskey-Harbor Springs Area Community Foundation Petoskey, MI PURPOSE: GENERAL SUPPORT, EVENING WITH THE STARS, GREAT STRIDES | $35,100 |
Saint Paul & Minnesota Foundation Saint Paul, MN PURPOSE: MULTIPLE PURPOSES | $31,000 |
Carlson Family Foundation Urbandale, IA PURPOSE: GENERAL FUND | $30,000 |
The Pruitt Foundation Inc Chantilly, VA PURPOSE: FURTHERANCE OF CHARITABLE PURPOSES | $30,000 |
Organization Name | Assets | Revenue |
---|---|---|
Cystic Fibrosis Foundation Bethesda, MD | $4,476,511,082 | $605,778,425 |
March Of Dimes Inc Arlington, VA | $74,954,887 | $100,854,404 |
United Cerebral Palsy Of Cental Pennsylvania Inc Camp Hill, PA | $15,115,971 | $35,421,008 |
Children And Adult Disability And Educational Services Swarthmore, PA | $25,589,840 | $29,555,003 |
Easter Seals Serving Dc-Md-Va Inc Silver Spring, MD | $37,760,577 | $20,667,344 |
Blossom Philadelphia Vicinity Philadelphia, PA | $11,542,334 | $13,231,911 |
Community Living And Support Services Inc Pittsburgh, PA | $14,170,450 | $10,575,358 |
Accessabilities Inc Butler, PA | $6,470,524 | $9,287,524 |
Community Care Connections Inc Butler, PA | $5,507,054 | $6,376,782 |
The Clinic For Special Children Inc Strasburg, PA | $13,470,361 | $8,177,464 |
Sickle Cell Disease Association Of America Inc Hanover, MD | $1,399,367 | $4,314,746 |
United Cerebral Palsy Of Northeastern Pa Scranton, PA | $3,591,664 | $4,899,608 |